Innovative financing has become increasingly central to debates on how to close the widening gap between global health needs and available funding. In a new Perspective in Global Health Research and Policy, Wang and colleagues argue that non-traditional mechanisms—ranging from solidarity levies and impact bonds to blended finance and results-based funding—can play a much larger role in achieving universal health coverage, particularly in the post-COVID era of constrained fiscal space. Drawing on World Bank and UN definitions, the authors describe innovative financing as the use of solidarity, public-private partnerships and catalytic tools to mobilize new resources and apply financial engineering to persistent health challenges. They review a wide spectrum of instruments that have already supported vaccines and other health priorities, from airline ticket levies and vaccine bonds to the Pandemic Fund, highlighting how these approaches have mobilized additional capital, brought in new partners and, in some cases, accelerated responses to outbreaks.
At the same time, the article conveys the limitations of current mechanisms: many are donor-driven, complex to manage, small in scale and only partially additional to existing aid flows. To move beyond boutique pilots, the authors call for a “reconfiguration” of innovative financing along four fronts: adopting a Global Public Investment lens that moves past the donor–recipient divide, deepening engagement with the private sector, tapping underused sources such as ESG-aligned capital and climate-linked investments, and strengthening operating models through blended concessional finance and robust impact evaluation. For immunization and other essential services, this agenda points toward financing models that are more predictable, more country-owned and better able to blend domestic, concessional and commercial resources—so that financial innovation translates into sustained, equitable health coverage rather than isolated success stories.
Thumbnail image credit: UNICEF/2023/Mapalo Mwenya
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.